Navigation Links
Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update
Date:11/7/2011

MOUNTAIN VIEW, Calif., Nov. 7, 2011 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today reported financial results for the fiscal quarter ended September 30, 2011 and provided a business update.  The net losses for the quarters ended September 30, 2011 and 2010, as reported in accordance with accounting principles generally accepted in the United States (GAAP), were $13.4 million and $0.6 million, respectively.  The net losses for the nine-month periods ended September 30, 2011 and 2010, were $30.8 million and $26.9 million, respectively.  At September 30, 2011, Alexza had consolidated cash, cash equivalents and marketable securities of $28.3 million.

"Since the acceptance of the resubmission of our ADSUVE NDA in August, we have made additional progress toward our corporate goals for 2011." said Thomas B. King, President and CEO of Alexza.  "We confirmed the FDA advisory committee meeting date on December 12, 2011 to discuss the ADASUVE NDA and we continue to look toward our PDUFA goal date of February 4, 2012."

King continued, "At the same time, we have also made great strides internationally. In addition to submitting the Marketing Authorization Application to the EMA, we announced a partnership with Grupo Ferrer to commercialize ADASUVE in Europe, Latin America, Russia, and the Commonwealth of Independent States (CIS) countries.  We believe we are poised to enter 2012 with momentum as we continue developing ADASUVE."

Alexza Business Update

The following key events, listed in chronological order, occurred since the beginning of the third quarter of 2011:

  • Alexza conducted a face-to-face meeting with the European Medicines Agency (EMA) assigned Co-Rapporteur and his review team in July 2011.
  • In August 2011, the U.S. Food and Drug Administration (FDA) accepted Alexza's resubmission of the Adasuve͐
    '/>"/>

  • SOURCE Alexza Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Alexza Pharmaceuticals to Present at the Lazard Capital Markets 8th Annual Healthcare Conference
    2. Alexza to Announce 2011 Third Quarter Financial Results on Monday, November 7, 2011
    3. Alexza Announces the Adasuve™ (Staccato® Loxapine) PDAC Meeting Date of December 12, 2011
    4. Alexza Pharmaceuticals to Present at the 18th Annual NewsMakers in the Biotech Industry Conference
    5. Alexza and Grupo Ferrer Establish Partnership for the Commercialization of Adasuve™ (Staccato® Loxapine) in Europe and Latin America
    6. Alexza Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
    7. Alexza Announces Adasuve™ (Staccato® Loxapine) PDUFA Goal Date of February 4, 2012
    8. Alexza Announces Resubmission of AZ-004 (Staccato® Loxapine) NDA
    9. Alexza to Announce 2011 Second Quarter Financial Results on Monday, August 8, 2011
    10. Alexza Reports 2011 First Quarter Financial Results and Provides Business Update
    11. Alexza to Present at the MDB Bright Lights Conference 2011
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... 23, 2015  Today the U.S. Food and Drug Administration ... prevention of serogroup B meningococcal disease in ... Trumenba®, which received FDA approval in October, represent a ... "I have heard over and over ...
    (Date:1/23/2015)... Jan. 23, 2015  The Partnership to Fight Chronic Disease (PFCD) released ... care leaders and a new study analyzing the impact of increased ... a nationwide coalition working to educate policy makers and the public ... Capitol was focused on how the Iowa ...
    (Date:1/23/2015)... 23, 2015 More than a third of reproductive-aged women ... with private insurance, filled a prescription for an opioid pain ... this week,s Morbidity and Mortality Weekly Report (MMWR). ... treat moderate to severe pain.  They are also found in ...
    Breaking Medicine Technology:The National Meningitis Association (NMA) Applauds FDA Approval of Second Vaccine To Protect Against Serogroup B Meningococcal Disease 2New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3
    ... Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer ... bioimplants processed from human amniotic membrane, announced today ... latest biologic implant processed to offer surgical and ... from the MiMedx Group,s proprietary Purion® process, AmnioFix™ ...
    ... LLP is pleased to announce the addition of partner ... Based in the New York office, Stronski is an ... the so-called "Hatch-Waxman" Amendments to the Federal Food Drug ... trademark, copyrights, and unfair competition matters. Stronski will be ...
    Cached Medicine Technology:MiMedx Announces Launch of AmnioFix™ Nerve Wrap 2Pharmaceutical Litigation Partner James Stronski Joins Crowell & Moring 2Pharmaceutical Litigation Partner James Stronski Joins Crowell & Moring 3
    (Date:1/22/2015)... The Incredible Bulk is a revolutionary method put together ... by up to 30lbs in less than 12 weeks without ... Stevenson, prompting an investigative review. , “Our Incredible Bulk ... formula that allows the body to pack on a massive ...
    (Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and ... Merchandise Show to bestow a Juvent Sports Achievement award ... Arlene McKitrick. The award commemorated and congratulated McKitrick for ... She won her first amateur tournament in 1979 and ...
    (Date:1/22/2015)... 22, 2015 Carinsurancesavings.biz has released a new ... and dismemberment insurance . , Purchasing an accidental death ... very advantageous. This type of rider provides benefits if the ... be considered a lesser form of life insurance. , ...
    (Date:1/22/2015)... City, Florida (PRWEB) January 22, 2015 IsoComforter, ... cold therapy machine with patented IsoTube design to treat specific ... has introduced the most progressive and easy to use patented ... treat post-operative and sports related orthopedic and muscle injuries. ...
    (Date:1/22/2015)... JJsHouse.com is a famous dress online store ... announces its latest collection of wedding dresses , and ... issue is the wedding dress on your big day; the ... life. Every bride wants to find the most suitable wedding ...
    Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
    ... BINGHAMTON, NY -- A Binghamton University researcher will receive ... support Parkinson,s research that will focus not only on ... side effects of treatment. , "Parkinson,s disease patients have ... psychology. "They move more slowly. They have rigidity in ...
    ... Practices, LLC launched,this research study exclusively for the ... practices in the sales force.,The two-pronged research approach, ... district managers and sales,representatives, reveals:, -- ... Percentage of time spent that is "unnecessary" ...
    ... following is being,issued by the National Academy of Social ... 2008, 3:30 pm Seminar: Growing Risks for Workers ... Insights from Behavioral Economics to Control Health Costs, ... Social Security Benefits, Stephen C. Goss, Chief Actuary ...
    ... Va., and CHARLESTON, S.C., May 28 ,The ... ) and The,HealthCentral Network, Inc. (http://www.HealthCentral.com ... Muller will join HealthCentral,s growing,community of patients, ... people suffering from incontinence. Muller will offer ...
    ... Chelsea Community Hospital, lead ,who,s who, of pain experts at May ... ... Mich., ANN ARBOR, Mich., May 28 Pain affects more ... for Health Statistics, pain affects 76.2 million people. The latest,research into ...
    ... (volume 8, issue 25) edition of the journal of ... from the bark of the French maritime pine tree, ... allows people to lower their antihypertensive medication and improves ... the University of Arizona, Tucson, indicates Pycnogenol may serve ...
    Cached Medicine News:Health News:$1.3M NIH grant to fund Parkinson's disease study 2Health News:Research Study Shows That Pharmaceutical Field Sales Reps' Productivity Inhibited by Unnecessary Internal Communication 2Health News:The National Association For Continence and The HealthCentral Network Form Alliance to Develop New Online Resources for Patients Coping with Incontinence 2Health News:The National Association For Continence and The HealthCentral Network Form Alliance to Develop New Online Resources for Patients Coping with Incontinence 3Health News:New Research and Treatment Options for Millions Suffering Headaches and Chronic Pain to be Presented at 10th Annual Headache and Pain Conference 2Health News:New Research and Treatment Options for Millions Suffering Headaches and Chronic Pain to be Presented at 10th Annual Headache and Pain Conference 3Health News:Study shows pine bark naturally reduces cardiovascular risk factors in diabetics 2Health News:Study shows pine bark naturally reduces cardiovascular risk factors in diabetics 3
    ... innovative, quick and easy automated refill ... less space on your laboratory bench ... amazingly easy-to-use, one-hand system, you only ... range of Diamond Tips. All sizes ...
    200 L, Racked, Pre-sterilized, 96 tips/rack Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less....
    MBP's extra long 200 L pipet tip will reach the bottom of large tubes and vials, preventing your pipettor from contacting the sample container....
    The BioCheck LH ELISA is intended for the quantitative determination of luteinizing hormone (LH) in human serum. This assay is useful in the diagnosis and treatment of gonadal dysfunction....
    Medicine Products: